Search Results 101-110 of 16417 for infliximab
Crohn's Disease Study on Infliximab, Azathioprine. Shawn Bishop. October 1, 2008. First · Previous ... 348 · 349 · 350 · 351 · Last · Sign up to receive email ...
The purpose of this study is to evaluate the effects of Remicade (infliximab) for the treatment of active Crohn's disease and may be useful in preventing a ...
Researchers revealed what appeared to be two separate health conditions stemmed from a single, shared genetic variant. Latest stories.
Demonstrated intolerance or inadequate response to one or more of the following biologic agents as defined below: infliximab, adalimumab, certolizumab pegol, ...
ROCHESTER, Minn. — Alzheimer's-related brain changes progressed up to 20 times faster in women who also had abnormal levels of a Parkinson's-related protein, ...
Gastroenterology. Crohn's Disease Study on Infliximab, Azathioprine. Shawn Bishop. October 1, 2008. First · Previous ... 348 · 349 · 350 · 351 · Last · Sign up ...
This article on a Mayo Clinic Regenerative Sciences Training Program student is taken from a series of articles that feature the work of graduate students[...] ...
Do not use this medicine together with adalimumab (Humira®), certolizumab pegol (Cimzia®), etanercept (Enbrel®), golimumab (Simponi®), or infliximab (Remicade®) ...
Two are the tumor necrosis factor inhibitors adalimumab, or Humira, and infliximab, or Remicade. These medicines work by dampening part of the immune system ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!